Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests 81€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests 184€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  2. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  3. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  4. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  5. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  6. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  7. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  8. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  9. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  10. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  11. Bahri R, et al. 2020. Methods Mol Biol. 2163:227. PubMed
  12. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  13. McIlwain DR, et al. 2021. Cell Host Microbe. 29:1828. PubMed
  14. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  15. Chang M, et al. 2022. Biotechnol Bioeng. 119:1820. PubMed
  16. Ioannidis LJ, et al. 2022. STAR Protoc. 3:101269. PubMed
  17. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  18. Mair F, et al. 2022. Nature. 605:728. PubMed
  19. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  20. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  21. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  22. Campisi L, et al. 2022. Nature. 606:945. PubMed
  23. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  24. Neely J, et al. 2022. Front Immunol. 13:902232. PubMed
  25. Feyaerts D, et al. 2022. Cell Rep Med. 3:100680. PubMed
  26. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  27. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  28. Calabrese DR, et al. 2022. JCI Insight. 7: . PubMed
  29. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  30. Messing M, et al. 2022. Front Immunol. 13:1010216. PubMed
  31. Wei H, et al. 2022. Front Immunol. 13:1060695. PubMed
  32. Wheeler MM, et al. 2022. Nat Commun. 13:7592. PubMed
  33. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  34. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  35. Kim JR, et al. 2022. Cancer Immunol Immunother. :. PubMed
  36. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  37. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  38. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  39. Chow A 2023. Immunity. 56(1):93-106.e6. PubMed
  40. Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed
  41. Sun W, et al. 2023. Nature. 614:309. PubMed
  42. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  43. Heinen N, et al. 2023. Front Immunol. 13:1062210. PubMed
  44. Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed
  45. De Bakshi D, et al. 2023. Life Sci Alliance. 6: . PubMed
  46. Liao J, et al. 2023. Nat Commun. 14:207. PubMed
  47. Li Z, et al. 2022. J Thorac Dis. 14:4815. PubMed
  48. Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed
  49. Wang CQ, et al. 2023. Cells. 12: . PubMed
  50. Mohamed H, et al. 2023. Biomedicines. 11: . PubMed
  51. Ty M, et al. 2023. Sci Transl Med. 15:eadd9012. PubMed
  52. Sadashivaiah V, et al. 2023. BMC Neurosci. 24:6. PubMed
  53. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  54. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  55. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  56. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  57. Nandi I, et al. 2023. J Clin Invest. :. PubMed
  58. Chen SH, et al. 2022. Neurosci Bull. 38:290. PubMed
  59. Miller CL, et al. 2022. Cell Chem Biol. 29:451. PubMed
  60. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  61. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  62. Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed
  63. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  64. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed
  65. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  66. Zhang X, et al. 2022. Cell Rep. 40:111363. PubMed
  67. Witkowski MT, et al. 2022. Nat Immunol. 23:1424. PubMed
  68. Gazinska P, et al. 2022. Clin Cancer Res. 28:4494. PubMed
  69. Li S, et al. 2022. Nature. 610:373. PubMed
  70. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  71. Ors A, et al. 2022. Nucleic Acids Res. 50:11492. PubMed
  72. Ainsua-Enrich E, et al. 2022. iScience. 25:105455. PubMed
  73. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  74. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  75. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  76. Imanishi M, et al. 2022. Front Cardiovasc Med. 9:988713. PubMed
  77. Ye D, et al. 2023. Cell Mol Neurobiol. 43:2337. PubMed
  78. Lai ZZ, et al. 2023. Front Immunol. 14:992765. PubMed
  79. Long D, et al. 2023. Eur J Immunol. 53:e2250109. PubMed
  80. Lareau CA, et al. 2023. Nat Protoc. 18:1416. PubMed
  81. Jun SH, et al. 2023. Nat Commun. 14:982. PubMed
  82. Ryan FJ, et al. 2023. Cell Rep Med. 4:100971. PubMed
  83. Lakkis J, et al. 2022. Nat Mach Intell. 4:940. PubMed
  84. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  85. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  86. Ishikawa M, et al. 2023. Front Immunol. 14:998233. PubMed
  87. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  88. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  89. Yao L, et al. 2022. Cancer Res Commun. 2:1255. PubMed
  90. Vasaikar SV, et al. 2023. Nat Commun. 14:1684. PubMed
  91. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  92. Gao F, et al. 2023. Immunity. 56:864. PubMed
  93. Pinto C, et al. 2023. iScience. 26:106381. PubMed
  94. Im KW, et al. 2023. NPJ Breast Cancer. 9:22. PubMed
  95. Wu T, et al. 2023. Nat Methods. 20:723. PubMed
  96. Luo Y, et al. 2023. Cell Discov. 9:40. PubMed
  97. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  98. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  99. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  100. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  101. Thomas KA, et al. 2023. Transfusion. :S146. PubMed
  102. Boucher LE, et al. 2023. MAbs. 15:2195517. PubMed
  103. Lafôrets F, et al. 2023. iScience. 26:106514. PubMed
  104. Chen DY, et al. 2023. iScience. 26:106634. PubMed
  105. Solier S, et al. 2023. Nature. 617:386. PubMed
  106. Bera BS, et al. 2023. Epigenetics Chromatin. 16:14. PubMed
  107. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  108. Luoma S, et al. 2023. Cancers (Basel). 15:. PubMed
  109. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  110. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  111. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  112. Allard-Chamard H, et al. 2023. Cell Rep. 42:112630. PubMed
  113. Potts M, et al. 2023. Cell Rep. 42:112613. PubMed
  114. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  115. Du J, et al. 2023. Nat Commun. 14:3675. PubMed
  116. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  117. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  118. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  119. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  120. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  121. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  122. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  123. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  124. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  125. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  126. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  127. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  128. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  129. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  130. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  131. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  132. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  133. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  134. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  135. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  136. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  137. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  138. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  139. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  140. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  141. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  142. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  143. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  144. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  145. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  146. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  147. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  148. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  149. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  150. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  151. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  152. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  153. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  154. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  155. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  156. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  157. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  158. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  159. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  160. Jairaman A, et al. 2022. Elife. 11:. PubMed
  161. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  162. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  163. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  164. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  165. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  166. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  167. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  168. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  169. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  170. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  171. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  172. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  173. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  174. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  175. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  176. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  177. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  178. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  179. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  180. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  181. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  182. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  183. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  184. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  185. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  186. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  187. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  188. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  189. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  190. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  191. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  192. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  193. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  194. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  195. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  196. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  197. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  198. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  199. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  200. Ogbe A, et al. 2022. JCI Insight. . PubMed
  201. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  202. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  203. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  204. Woodruff MC, et al. 2022. Nature. :. PubMed
  205. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  206. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  207. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  208. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  209. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  210. Dogra P, et al. 2020. Cell. 749:180. PubMed
  211. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  212. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  213. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  214. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  215. Kumar V, et al. 2022. Cells. 11:. PubMed
  216. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  217. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  218. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  219. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  220. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  221. Vijayakumar B, et al. 2022. Immunity. . PubMed
  222. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  223. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  224. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  225. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  226. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  227. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  228. Kreutmair S, et al. 2021. Immunity. . PubMed
  229. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  230. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  231. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  232. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  233. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  234. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  235. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  236. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  237. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  238. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  239. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  240. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  241. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  242. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  243. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  244. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  245. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  246. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  247. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  248. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  249. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  250. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  251. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  252. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  253. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  254. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  255. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  256. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  257. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  258. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  259. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  260. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  261. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  262. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  263. Romine KA, et al. 2021. Cancer Discov. . PubMed
  264. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  265. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  266. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  267. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  268. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  269. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  270. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  271. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  272. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  273. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  274. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  275. Shi J, et al. 2014. Blood. 123:4015. PubMed
  276. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  277. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  278. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  279. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  280. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  281. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  282. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  283. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  284. Thijssen R, et al. 2022. Blood. :. PubMed
  285. Good Z, et al. 2022. Nat Med. :. PubMed
  286. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  287. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  288. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  289. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  290. Woodruff M, et al. 2020. medRxiv. . PubMed
  291. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  292. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  293. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  294. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  295. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  296. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  297. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  298. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  299. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  300. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  301. Burns JC, et al. 2020. eLife. 9:00. PubMed
  302. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  303. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  304. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  305. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  306. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  307. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  308. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  309. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  310. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  311. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  312. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  313. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  314. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  315. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  316. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  317. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  318. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  319. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  320. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  321. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  322. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  323. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  324. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  325. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  326. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  327. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  328. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  329. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  330. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  331. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  332. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  333. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  334. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  335. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  336. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  337. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  338. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  339. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  340. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  341. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  342. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  343. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  344. Wang J, et al. 2022. iScience. 25:103971. PubMed
  345. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  346. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  347. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  348. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  349. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  350. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  351. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  352. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  353. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  354. Feng W, et al. 2020. J Vis Exp. . PubMed
  355. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  356. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  357. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  358. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  359. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  360. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  361. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  362. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  363. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  364. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  365. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  366. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  367. Song M, et al. 2018. Nature. 562:423. PubMed
  368. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  369. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  370. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  371. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  372. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  373. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  374. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  375. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  376. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  377. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  378. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  379. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  380. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  381. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  382. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  383. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  384. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  385. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  386. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  387. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  388. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  389. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  390. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  391. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  392. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  393. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  394. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  395. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  396. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  397. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  398. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  399. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  400. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  401. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  402. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  403. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  404. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  405. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  406. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  407. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  408. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  409. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  410. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  411. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  412. Georg P, et al. 2022. Cell. 185:493. PubMed
  413. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  414. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  415. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  416. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  417. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  418. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  419. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  420. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  421. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  422. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  423. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  424. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  425. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  426. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  427. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  428. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  429. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  430. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  431. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  432. Lederer K, et al. 2022. Cell. . PubMed
  433. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  434. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  435. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  436. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  437. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  438. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  439. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  440. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  441. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  442. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  443. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  444. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  445. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  446. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  447. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  448. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  449. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  450. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  451. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  452. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  453. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  454. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  455. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  456. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  457. Adamo S, et al. 2022. Nature. 602:148. PubMed
  458. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  459. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  460. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  461. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  462. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  463. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  464. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  465. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  466. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  467. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  468. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  469. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  470. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  471. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  472. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  473. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  474. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  475. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  476. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  477. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  478. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  479. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  480. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  481. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  482. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  483. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  484. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  485. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  486. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  487. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  488. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  489. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  490. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  491. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  492. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  493. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  494. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  495. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  496. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  497. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  498. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  499. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  500. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  501. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  502. Chen C, et al. 2022. iScience. 25:103645. PubMed
  503. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  504. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  505. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  506. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  507. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  508. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  509. Wang EY, et al. 2021. Nature. 595:283. PubMed
  510. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  511. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  512. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  513. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  514. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  515. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  516. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  517. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  518. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  519. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  520. Binnewies M, et al. 2019. Cell. 177:556. PubMed
  521. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  522. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  523. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  524. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  525. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  526. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  527. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  528. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  529. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07/14/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account